Published in Thromb Res on February 01, 1983
Endothelial stimulation of intimal cell proliferation in a porcine aortic organ culture. Am J Pathol (1989) 1.05
Value of factor VIII related antigen as a means of demonstrating extramedullary megakaryopoiesis. J Clin Pathol (1984) 0.94
Isolation and short term culture of canine adrenal microvascular endothelial cells. Can J Vet Res (1999) 0.75
Factor 8 on the vascular intima: possible importance in haemostasis and thrombosis. Nat New Biol (1973) 2.43
Increased factor IX levels in puerperium during administration of diethylstilboestrol. Br Med J (1968) 2.29
Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group. N Engl J Med (1990) 2.05
Carrier detection by direct gene analysis in a family with haemophilia B (factor IX deficiency). Lancet (1984) 1.74
STRAIN ELECTROMETRY AND CORROSION I. GENERAL CONSIDERATIONS ON INTERFACIAL ELECTRICAL TRANSIENTS. Proc Natl Acad Sci U S A (1957) 1.39
Inherited variants of factor-VIII-related protein in von Willebrand's disease. N Engl J Med (1974) 1.36
Postoperative problems and management after hepatic resection for blunt injury to the liver. Br J Surg (1975) 1.30
Flow-field-flow fractionation: a versatile new separation method. Science (1976) 1.26
Two-dimensional separations: concept and promise. Anal Chem (1984) 1.24
Rapid diffusion coefficient measurements using analytical SPLITT fractionation: application to proteins. Anal Biochem (1993) 1.20
The von Willebrand syndrome. Semin Hematol (1980) 1.19
The localization of factor V within normal human platelets and the demonstration of a platelet-factor V antigen in congenital factor V deficiency. Br J Haematol (1975) 1.15
A clinical and experimental study of platelet function in chronic renal failure. J Clin Pathol (1972) 1.14
Electrical field-flow fractionation of proteins. Science (1972) 1.13
Facile and rapid analysis of three DNA polymorphisms within the human factor IX gene using the polymerase chain reaction. Br J Haematol (1991) 1.13
Heterogeneity of the factor IX locus in nine hemophilia B inhibitor patients. J Clin Invest (1987) 1.12
Inherited thrombocytopenia, elevated serum IgA and renal disease: identification as a variant of the Wiskott-Aldrich syndrome. Q J Med (1986) 1.12
HTLV-III antibody status and immunological abnormalities in haemophilic patients. Lancet (1985) 1.12
Epsilon-Aminocaproic acid therapy for dental extractions in haemophilia and Christmas disease: a double blind controlled trial. Br J Haematol (1971) 1.07
Properties of an asymmetrical flow field-flow fractionation channel having one permeable wall. Anal Chem (1987) 1.07
Intravascular coagulation and the liver. Br J Haematol (1975) 1.04
Immunological studies in combined factor V and factor VIII deficiency. Br J Haematol (1977) 1.00
The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities. Br J Haematol (1984) 1.00
Rapid protein separation and diffusion coefficient measurement by frit inlet flow field-flow fractionation. Protein Sci (1993) 0.99
Changes in Blood After Using an Extracorporeal Circulation. Br Med J (1961) 0.97
A study of cell mediated and humoral immunity in haemophilia and related disorders. Br J Haematol (1985) 0.97
Carrier detection in 50 haemophilia A kindred by means of three intragenic and two extragenic restriction fragment length polymorphisms. Br J Haematol (1988) 0.97
Defibrination syndrome with defective thrombinfibrinogen reaction reversible by protamine. J Clin Pathol (1965) 0.97
Tentative protocol for the evaluation of coagulometers, based on one-stage prothrombin time. Clin Lab Haematol (1981) 0.97
Immunoradiometric assay of procoagulant factor-VIII antigen in plasma and serum and its reduction in haemophilia. Preliminary studies on adult and fetal blood. Lancet (1978) 0.96
Linked and intragenic probes for haemophilia A. Lancet (1985) 0.96
Fractionating power in programmed field-flow fractionation: exponential sedimentation field decay. Anal Chem (1987) 0.95
Value of factor VIII related antigen as a means of demonstrating extramedullary megakaryopoiesis. J Clin Pathol (1984) 0.94
The use of an immunoradiometric assay for factor VIII related antigen in the study of atypical Von Willebrand's disease. Thromb Res (1977) 0.94
Separation of human and animal cells by steric field-flow fractionation. Cell Biophys (1984) 0.94
Flow field-flow fractionation: new method for separating, purifying, and characterizing the diffusivity of viruses. J Virol (1977) 0.93
Hydrodynamic relaxation in flow field-flow fractionation using both split and frit inlets. Anal Chem (1991) 0.93
A Large Drop in Atmospheric 14C/12C and Reduced Melting in the Younger Dryas, Documented with 230Th Ages of Corals. Science (1993) 0.93
Platelet counts and aggregates in coronary artery disease. Eur Heart J (1982) 0.91
Factor VIII (antihaemophilic factor) in tissues detected by antibody neutralization. Br J Haematol (1972) 0.90
Preparation and use of a new artificial system for factor XI assay. Med Lab Technol (1971) 0.90
Varying the ratio of dietary n-6/n-3 polyunsaturated fatty acid alters the tendency to thrombosis and progress of atherosclerosis in apoE-/- LDLR-/- double knockout mouse. Thromb Res (2005) 0.90
Factor VIII levels and blood group antigens. Thromb Haemost (1983) 0.90
Defective propeptide processing and abnormal activation underlie the molecular pathology of factor IX Troed-y-Rhiw. Br J Haematol (1989) 0.89
Adenosine diphosphate and the measurement of platelet adhesiveness. J Clin Pathol (1967) 0.89
Tissue localization and synthesis of factor-VIII-related antigen in the human foetus. Br J Haematol (1974) 0.88
Statistical method for estimation of number of components from single complex chromatograms: theory, computer-based testing, and analysis of errors. Anal Chem (1985) 0.88
HTLV-III, haemophilia, and blood transfusion. Br Med J (Clin Res Ed) (1985) 0.87
The immunological localization of factor V in human tissue. Br J Haematol (1975) 0.87
Immunoassays of factor IX antigen using monoclonal antibodies. Br J Haematol (1985) 0.87
Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor. Haemophilia (2004) 0.87
Water-formed structures: geomorphology and hydrology of karst terrains. Science (1989) 0.86
Synthesis of procoagulant factor VIII, factor VIII related antigen and other coagulation factors by the isolated perfused rat liver. Br J Haematol (1979) 0.86
Factor IX Cardiff: a variant factor IX protein that shows abnormal activation is caused by an arginine to cysteine substitution at position 145. Br J Haematol (1989) 0.86
A study of two methods for estimating plasma fibrinogen and the effect of epsilon aminocaproic acid and protamine. J Clin Pathol (1971) 0.86
Coagulation studies in massive pulmonary haemorrhage of the newborn. J Clin Pathol (1966) 0.86
Measurement of anti-factor IX IgG subclasses in haemophilia B patients who developed inhibitors with episodes of allergic reactions to factor IX concentrates. Thromb Res (1996) 0.85
Abnormal factor VIII related antigen (FVIIIRAG) in von Willebrand's disease (vWd): decreased precipitation by concanavalin A. Thromb Haemost (1977) 0.85
Familial haemostatic defect associated with reduced prothrombin consumption. Br J Haematol (1980) 0.85
Atherosclerosis and von Willebrand factor. I. Prevalence of severe von Willebrand's disease in western Europe and Israel. Br J Haematol (1984) 0.85
Successful treatment of two brothers with congenital afibrinogenemia for splenic rupture using heat- and solvent detergent-treated fibrinogen concentrates. J Pediatr Hematol Oncol (1997) 0.85
Characterization of procoagulant activity produced by cultures of human monocytes and lymphocytes separated in colloidal silica-polvinylpyrrolidone gradients. Clin Lab Haematol (1980) 0.85
Segregation of a pure form of spastic paraplegia and NOR insertion into Xq11.2. Am J Med Genet (2000) 0.84
Separation and size distribution of red blood cells of diverse size, shape, and origin by flow/hyperlayer field-flow fractionation. Anal Biochem (1993) 0.84
Immunological characterization of factor VIII autoantibodies in patients with acquired hemophilia A in the presence or absence of underlying disease. Thromb Res (2001) 0.84
High-speed particle separation and steric inversion in thin flow field-flow fractionation channels. J Chromatogr A (1996) 0.84
Comparison of power and exponential field programming in field-flow fractionation. J Chromatogr (1991) 0.84
Plasma-fibrinogen and the aggregation of platelets by adenosine diphosphate. Lancet (1969) 0.84
Recombination between genes and closely linked polymorphisms. Lancet (1986) 0.84
Acquired immunodeficiency syndrome and other possible immunological disorders in European haemophiliacs. Lancet (1984) 0.83
Statistical method for estimation of number of components from single complex chromatograms: application to experimental chromatograms. Anal Chem (1985) 0.83
Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease. Br J Haematol (1980) 0.83
Orthognathic surgery in a patient with Noonan's syndrome. J Oral Maxillofac Surg (1994) 0.83
The biosynthesis of factor VIII. Clin Haematol (1979) 0.83
Theory of field-programmed field-flow fractionation with corrections for steric effects. Anal Chem (1994) 0.83
A data analysis algorithm for programmed field-flow fractionation. Anal Chem (2001) 0.83
An immunoradiometric assay for procoagulant factor VIII antigen: results in haemophilia, von Willebrand's disease and fetal plasma and serum. Br J Haematol (1979) 0.83
Comparison of qucik and slow thaw methods of producing cryoprecipitate antihaemophilic factor from fresh and 24-hour-old blood. J Clin Pathol (1969) 0.83
Determination of mean diameter and particle size distribution of acrylate latex using flow field-flow fractionation, photon correlation spectroscopy, and electron microscopy. Anal Chem (1996) 0.83
A mutation adjacent to the beta cleavage site of factor IX (valine 182 to leucine) results in mild haemophilia Bm. Br J Haematol (1990) 0.83
Origin and characterization of departures from the statistical model of component-peak overlap in chromatography. J Chromatogr (1984) 0.82